Nanjing Leads Biolabs Co., Ltd. (09887) published its monthly return for the period ended 28 February 2026, reporting no changes in issued share capital during the month. The total authorized share capital remained at RMB 198.89 million, comprised of 153.28 million H shares listed on The Stock Exchange of Hong Kong and 45.61 million unlisted shares.
According to the announcement, the public float requirement for the H shares has been met. No share options, warrants, or convertible securities were declared, and there were no treasury shares reported.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments